SBI JI
Israelsbi-ji.co.il
Overview
SBI JI is a venture capital firm formed in 2017 as a partnership between Japan's SBI Holdings and Israel's Vertex Venture Capital. The firm initially focused on bio-investments and has since expanded to other high-tech sectors. It primarily invests in Israeli or Israel-related venture-backed companies across various development stages, with a tendency to enter at Series B. Its investment portfolio includes companies in Life Sciences, High Tech, and Enterprise Applications.
Portfolio Companies
10
Website
sbi-ji.co.ilInvestments
| Company | Date | Stage | Lead |
|---|---|---|---|
| Secret Double Octopus | Oct 2024 | Series C Extension | - |
| Orasis Pharmaceuticals | Oct 2024 | Series D | Co-investor |
| One Zero Digital Bank Ltd. | Dec 2021 | Series A | - |
| Orasis Pharmaceuticals | Sep 2020 | Series C | Lead |
| Biond Biologics | Jan 2019 | Series B | Co-investor |
Sector & Stage Mix
Industry, funding stage, and valuation band breakdowns.
